Author:
Belforte Juan E,Zsiros Veronika,Sklar Elyse R,Jiang Zhihong,Yu Gu,Li Yuqing,Quinlan Elizabeth M,Nakazawa Kazu
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Lodge, D. & Anis, N.A. Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. Eur. J. Pharmacol. 77, 203–204 (1982).
2. Javitt, D.C. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J. Clin. Psychiatry 9, 12–35 (1987).
3. Olney, J.W. in Excitatory Acid Acids in Health and Disease (ed. D. Lodge) 337–351 (Wiley, London, 1988).
4. Deutsch, S.I., Mastropaolo, J., Schwartz, B.L., Rosse, R.B. & Morihisa, J.M.A. “glutamatergic hypothesis” of schizophrenia. Rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 12, 1–13 (1989).
5. Krystal, J.H. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199–214 (1994).
Cited by
645 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献